Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

November 30, 2007

Conditions
Prostate Cancer
Interventions
DRUG

leuprolide acetate

Trial Locations (28)

11530

AccuMed Research Associates, Garden City

Urological Surgeons of Long Island, Garden City

12401

Hudson Valley Urology, Kingston

12601

Hudson Valley Urology, Poughkeepsie

20132

Sexual Medicine Unit and Urology, Università Vita Salute San Raffaele Fondazione Centro San Raffaele del Monte Tabor, Milan

29572

Carolina Urologic Research Center, Myrtle Beach

33907

Southwest Florida Urologic Associates, Fort Myers

34237

Florida Urology Specialists, Sarasota

34652

Advanced Research Institute, Inc., New Port Richey

35209

Urology Centers of Alabama, Homewood

37209

Urology Associates, PC, Nashville

39100

Department of Urology, General Hospital of Bolzano, Bolzano

49085

Lakeside Urology, Saint Joseph

71106

Regional Urology, Shreveport

85222

Desert Oasis Cancer Center, Casa Granda

08690

Hamilton Urology, P.A., Hamilton

08648

Lawrenceville Urology, Lawrenceville

A-1090

Department of Urology, Vienna University Medical School, Vienna

120 00

Urocentrum Praha, Prague

Unknown

Charles University, Clinic of Urology, Prague

Urology Department, Hviezdoslavova, Prague

Department of Urology, Jessenius Faculty of Medicine, Comenius University, Martin

401 13

Masaryk Hospital, Urology Dept., Ústí nad Labem

01307

Department of Urology, Technical University of Dresden, Dresden

H-1082

Department of Urology, Semmelweis University, Budapest

H-7621

Department of Urology, Medical School, University of Pécs, Pécs

08907

Institut Català d'Oncologia, Hospital Duran I Reynals, Servicio de Oncologia Medica, Barcelona

NW3 2QG

Royal Free Hospital and School of Medicine, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GP-Pharm

INDUSTRY